MedPath

To evaluate the effect of herbal medicine in prevention and management of COVID-19

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/06/025672
Lead Sponsor
Ministry of AYUSH Government of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Definite diagnosis of COVID-19; fulfilling WHO case definition, including a positive PCR from any specimen (e.g. respiratory, blood, urine, stool, other bodily fluid) and presence of one or more of the following associated symptoms-

cough

fever ( > 37.5° C / 99.5° F)

shortness of breath

sore throat

2. Hospitalized patients with no oxygen therapy or oxygen by mask or nasal prongs.

3. Understand and agreed to comply with the study

Exclusion Criteria

1. Patient below 18 year of age.

2. K/c/o Cardiovascular diseases like Ischaemic heart disease, Coronary Artery disease.

3. K/c/o Chronic Kidney disease, Chronic Lung disease, Chronic neurological disorder, Pulmonary Tuberculosis.

4. Pregnant and Lactating women.

5. Patient on non-invasive ventilation or high flow oxygen.

6. Patient on intubation and mechanical ventilation.

7. Patient on ventilation + additional organ support-pressor, RRT, ECMO.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome will be focused on decrease severity of parameters: <br/ ><br>â?? Fever <br/ ><br>â?? Sore Throat, Cough with sputum, Cough with haemoptysis, Dyspnoea (Shortness of breath), Wheezing, Chest pain, Runny nose, Fatigue, Headache, Arthralgia, Irritability/confusion, Seizures, Nausea/Vomiting, Diarrhoea, Abdominal pain, skin rashesTimepoint: 0th Day, 14th Day and 21st Day
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath